公众号 / 文章胸部技术与安全CT

实施肺癌筛查:美国经验

Implementing lung cancer screening: the US experience.
PubMed 文献 · Clin Radiol · 2017-01-06

美国国立肺筛查试验(NLST)显示低剂量CT(LDCT)筛查可降低肺癌死亡率,美国据此将年度筛查纳入私立保险和联邦医疗保险(CMS)的覆盖范围。报销要求将所有受筛者数据提交联邦登记,并记录患者资格、共享决策、戒烟咨询和年度筛查重要性。影像科可在满足这些要求之外,系统收集筛查检出和偶然检出肺结节的数据,以优化患者选择和结节管理。

要点

  • LDCT筛查报销需向联邦登记提交所有受筛者数据,并记录资格、共享决策、戒烟咨询及年度筛查重要性。
  • 现行结节管理和追踪指南降低了NLST中的假阳性率,但正确分类结节良恶性的能力仍有不足。
  • 影像医生可系统收集纵向数据,以改进筛查资格和不确定结节管理,并利用筛查场景促进戒烟。

核心结论

  • NLST中LDCT筛查观察到肺癌死亡率降低,促成美国将年度筛查纳入私立保险和联邦医疗保险(CMS)的覆盖福利。
  • 报销要求提交所有受筛者数据至联邦登记,并记录患者资格、共享决策、戒烟咨询及年度筛查重要性。
  • 影像医生可通过系统收集筛查检出和偶然检出肺结节的纵向数据,改进筛查资格和不确定结节管理,并利用筛查场景促进戒烟。

研究设计与样本

  • 本文为美国LDCT肺癌筛查实施经验的文章,涉及NLST结果、美国保险覆盖与报销要求、联邦登记数据提交及结节管理指南。
  • 报销要求数据提交覆盖所有受筛个体,无论私立或联邦保险,并记录患者资格、共享决策、戒烟咨询和年度筛查重要性。

诊断标准与关键数值

  • 报销要求记录个体患者资格、关于LDCT筛查获益与风险的共享决策、戒烟咨询以及年度筛查的重要性。
  • 当前结节管理和追踪指南降低了NLST中观察到的假阳性率,但在正确分类结节良恶性方面仍有不足。

临床应用与阅片要点

  • 影像科可在满足报销要求之外,系统收集筛查检出和偶然检出肺结节的纵向数据,以改进患者选择和不确定结节管理。
  • 影像医生可利用筛查场景激励并提供戒烟支持,因影像医生是烟草相关肺疾病纵向数据的独特收集者。
  • 通过重新设计影像实践理念,放射科医生可成为肺癌早期检测和死亡率降低的重要贡献者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

The reduced lung cancer mortality observed with low-dose computed tomography (LDCT) screening in the National Lung Screening Trial (NLST) has led to annual screening in the United States as a covered benefit by both private insurers and the federal health insurance programme, the Centers for Medicare and Medicaid Services. Reimbursement for screening requires data submission to a federal registry on all individuals, whether privately or federally insured. Data must document individual patient eligibility as well as shared decision-making regarding the benefits and risks of LDCT screening, smoking cessation counselling, and the importance of annual screening. Beyond these requirements lie opportunities to maximise the benefits of screening in the radiology setting. Individuals eligible for screening account for a minority of those diagnosed with lung cancer in the US; the evidence needed to improve patient selection must be collected systematically for both screen-detected and incidentally detected lung nodules. Current nodule management and tracking guidelines reduce the false-positive rates observed in the NLST, but fall short in their ability to correctly classify nodules as benign or malignant. Smoking cessation is inadequately managed in most busy clinician practices. As a common nidus for tobacco-associated lung diseases, imagers are uniquely poised to collect the longitudinal data to better inform screening eligibility and to improve indeterminate nodule management, while maximising the setting of screening to motivate and provide smoking cessation. By re-engineering the notion of imaging practice, radiologists can be major contributors to lung cancer early detection and mortality reduction.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Aberle DR. Implementing lung cancer screening: the US experience. Clin Radiol. 2017. PMID: 28069160. doi:10.1016/j.crad.2016.12.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。